|
1
|
Tsai YC, Wu CT and Hong RL: Response of
refractory osteosarcoma to thalidomide and celecoxib. Lancet Oncol.
6:997–999. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhang W, Li Q, Song C and Lao L: Knockdown
of autophagy-related protein 6, Beclin-1, decreases cell growth,
invasion, and metastasis and has a positive effect on
chemotherapy-induced cytotoxicity in osteosarcoma cells. Tumour
Biol. 36:2531–2539. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Xie Z, Xie Y, Xu Y, Zhou H, Xu W and Dong
Q: Bafilomycin A1 inhibits autophagy and induces apoptosis in MG63
osteosarcoma cells. Mol Med Rep. 10:1103–1107. 2014.PubMed/NCBI
|
|
4
|
Kim HJ, Lee SG, Kim YJ, Park JE, Lee KY,
Yoo YH and Kim JM: Cytoprotective role of autophagy during
paclitaxel-induced apoptosis in Saos-2 osteosarcoma cells. Int J
Oncol. 42:1985–1992. 2013.PubMed/NCBI
|
|
5
|
Levine B and Kroemer G: Autophagy in the
pathogenesis of disease. Cell. 132:27–42. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
He L and Hannon GJ: MicroRNAs: Small RNAs
with a big role in gene regulation. Nat Rev Genet. 5:522–531. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Calin GA, Sevignani C, Dumitru CD, Hyslop
T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M
and Croce CM: Human microRNA genes are frequently located at
fragile sites and genomic regions involved in cancers. Proc Natl
Acad Sci USA. 101:2999–3004. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang Y, Fu J, Jiang M, Zhang X, Cheng L,
Xu X, Fan Z, Zhang J, Ye Q and Song H: MiR-410 is overexpressed in
liver and colorectal tumors and enhances tumor cell growth by
silencing FHL1 via a direct/indirect mechanism. PLoS One.
9:e1087082014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Labialle S, Marty V, Bortolin-Cavaillé ML,
Hoareau-Osman M, Pradère JP, Valet P, Martin PG and Cavaillé J: The
miR-379/miR-410 cluster at the imprinted Dlk1-Dio3 domain controls
neonatal metabolic adaptation. EMBO J. 33:2216–2230. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen L, Zhang J, Feng Y, Li R, Sun X, Du
W, Piao X, Wang H, Yang D, Sun Y, et al: MiR-410 regulates MET to
influence the proliferation and invasion of glioma. Int J Biochem
Cell Biol. 44:1711–1717. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Huang J, Ni J, Liu K, Yu Y, Xie M, Kang R,
Vernon P, Cao L and Tang D: HMGB1 promotes drug resistance in
osteosarcoma. Cancer Res. 72:230–238. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lambert LA, Qiao N, Hunt KK, Lambert DH,
Mills GB, Meijer L and Keyomarsi K: Autophagy: A novel mechanism of
synergistic cytotoxicity between doxorubicin and roscovitine in a
sarcoma model. Cancer Res. 68:7966–7974. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhao Z, Tao L, Shen C, Liu B, Yang Z and
Tao H: Silencing of Barkor/ATG14 sensitizes osteosarcoma cells to
cisplatin-induced apoptosis. Int J Mol Med. 33:271–276.
2014.PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cadwell K, Patel KK, Komatsu M, Virgin HW
IV and Stappenbeck TS: A common role for Atg16L1, Atg5 and Atg7 in
small intestinal Paneth cells and Crohn disease. Autophagy.
5:250–252. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhao D, Yuan H, Yi F, Meng C and Zhu Q:
Autophagy prevents doxorubicin-induced apoptosis in osteosarcoma.
Mol Med Rep. 9:1975–1981. 2014.PubMed/NCBI
|
|
18
|
Mu Y, Zhang H, Che L and Li K: Clinical
significance of microRNA-183/Ezrin axis in judging the prognosis of
patients with osteosarcoma. Med Oncol. 31:8212014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yu L, McPhee CK, Zheng L, Mardones GA,
Rong Y, Peng J, Mi N, Zhao Y, Liu Z, Wan F, et al: Termination of
autophagy and reformation of lysosomes regulated by mTOR. Nature.
465:942–946. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Behrends C, Sowa ME, Gygi SP and Harper
JW: Network organization of the human autophagy system. Nature.
466:68–76. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yao F, Wang G, Wei W, Tu Y, Tong H and Sun
S: An autophagy inhibitor enhances the inhibition of cell
proliferation induced by a proteasome inhibitor in MCF-7 cells. Mol
Med Rep. 5:84–88. 2012.PubMed/NCBI
|
|
22
|
Yang C and Han LO: Knockdown of Beclin 1
inhibits vitamin K3-induced autophagy, but promotes apoptosis of
human hepatoma SMMC-7721 cells. Mol Med Rep. 3:801–807.
2010.PubMed/NCBI
|
|
23
|
Apel A, Herr I, Schwarz H, Rodemann HP and
Mayer A: Blocked autophagy sensitizes resistant carcinoma cells to
radiation therapy. Cancer Res. 68:1485–1494. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang J, Yan YG, Wang C, Zhang SJ, Yu XH
and Wang WJ: MicroRNAs in osteosarcoma. Clin Chim Acta. 444:9–17.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shen J, Niu W, Zhou M and Zhang H, Ma J,
Wang L and Zhang H: MicroRNA-410 suppresses migration and invasion
by targeting MDM2 in gastric cancer. PLoS One. 9:e1045102014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen N, Wang J, Hu Y, Cui B, Li W, Xu G,
Liu L and Liu S: MicroRNA-410 reduces the expression of vascular
endothelial growth factor and inhibits oxygen-induced retinal
neovascularization. PLoS One. 9:e956652014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen L, Jiang K, Jiang H and Wei P:
miR-155 mediates drug resistance in osteosarcoma cells via inducing
autophagy. Exp Ther Med. 8:527–532. 2014.PubMed/NCBI
|
|
28
|
Li X, Wang S, Chen Y, Liu G and Yang X:
miR-22 targets the 3′ UTR of HMGB1 and inhibits the
HMGB1-associated autophagy in osteosarcoma cells during
chemotherapy. Tumour Biol. 35:6021–6028. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shen C, Wang W, Tao L, Liu B, Yang Z and
Tao H: Chloroquine blocks the autophagic process in
cisplatin-resistant osteosarcoma cells by regulating the expression
of p62/SQSTM1. Int J Mol Med. 32:448–456. 2013.PubMed/NCBI
|
|
30
|
Wu W, Li W, Zhou Y and Zhang C: Inhibition
of beclin1 affects the chemotherapeutic sensitivity of
osteosarcoma. Int J Clin Exp Pathol. 7:7114–7122. 2014.PubMed/NCBI
|
